Results 281 to 290 of about 3,812,603 (397)
Converting laundry work of women in underdeveloped countries from risk of musculoskeletal disorders to a sustainable intervention: A design with holistic approach [PDF]
Banu Çiçek Avcıoğlu, Hüdayim Başak
openalex +1 more source
Aims This work aimed to contextualize glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonists safety and efficacy regarding weight management (WM); we analysed Food and Drug Administration (FDA) Medical Reviews to analyse 14 medications using patient‐exposure year normalization and ...
Aishwarya Prasad +4 more
wiley +1 more source
Occupational and Environmental Determinants of Musculoskeletal Disorders Among Nurses in Conflict-Affected Gaza Hospitals. [PDF]
Eleiwa AZ, Khadoura KJ.
europepmc +1 more source
Abstract The availability of safety data, particularly concerning adverse events (AEs) associated with the new shorter regimen for drug‐resistant tuberculosis (TB) containing a bedaquiline–pretomanid‐based regimen, is still limited. This systematic review aims to provide a comprehensive and updated analysis of AEs related to this new regimen by ...
Nisa Maria +4 more
wiley +1 more source
The effect of an adjunct psychosomatic intervention on perceived pain in patients with musculoskeletal disorders: protocol for a randomized controlled trial. [PDF]
Walter N +4 more
europepmc +1 more source
Abstract Background and Purpose Drug–drug interactions (DDIs) are associated with an increased risk of adverse drug reactions (ADRs). Hospitalized children are particularly vulnerable to DDIs and ADRs due to polypharmacy, frequent use of unlicensed or off‐label medications, and dosing regimens often extrapolated from adult data.
Emilie Laval +6 more
wiley +1 more source
Arabic translation, cross-cultural adaptation, and validation of the Expectation for Treatment Scale (ETS) in patients with musculoskeletal disorders. [PDF]
Mohamed W, Hall M, Barth J, Hendrick P.
europepmc +1 more source
Aim Intradermal application of lipopolysaccharide (LPS), a Toll‐like receptor 4 agonist, induces a local inflammatory response and is used as a human challenge model to evaluate the pharmacodynamics of investigational medicinal products. While currently applied in a single, parallel‐group setting, alternative within‐subject designs involving repeated ...
Alexandra A. J. Sillé +12 more
wiley +1 more source

